Phibro Animal Health | PAHC - 资产

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.06B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	资产	更改		日
Align Technology	USD 6.23B		141K	2025-12
ANI Pharmaceuticals	USD 1.44B		32.22M	2025-12
Assertio Holdings	USD 319.77M		46M	2025-09
Aurora Cannabis	CAD 775.29M		18.43M	2025-12
Bristol-Myers Squibb	USD 96.89B		2.21B	2025-09
Canopy Growth	CAD 1.11B		36.35M	2025-12
Corcept Therapeutics	USD 836.65M		13.04M	2025-12
Eli Lilly	USD 112.48B		2.46B	2025-12
Henry Schein	USD 11.22B		118M	2025-12
Idexx Laboratories	USD 3.35B		35.95M	2025-12
Knight Therapeutics	CAD 1.05B		2.28M	2025-12
Merck	USD 129.55B		12.02B	2025-09
Nektar Therapeutics	USD 301.35M		93.81M	2025-09
Pacira	USD 1.26B		32.66M	2025-12
Phibro Animal Health	USD 1.41B		20.03M	2025-12
Prestige Brands	USD 3.49B		52.46M	2025-12
Supernus Pharmaceuticals	USD 1.45B		32.89M	2025-12
Zoetis	USD 15.47B		308M	2025-12